Company Filing History:
Years Active: 2025
Title: Innovations by Carlos Mora in Extracorporeal Treatment
Introduction
Carlos Mora is an innovative inventor based in Zürich, Switzerland. He has made significant contributions to the field of medical technology, particularly in the treatment of sepsis. His work focuses on developing methods that enhance the efficacy of extracorporeal treatments for patients suffering from this serious condition.
Latest Patents
Carlos Mora holds a patent for an "Assembly for extracorporeal treatment of body fluids." This invention outlines a method for the extracorporeal treatment of a body fluid from a patient suffering from sepsis. The process involves removing harmful substances from the patient's body fluid through a series of steps, including the injection of a mixture containing functionalized magnetic particles. This innovative approach aims to reduce the concentration of target molecules in the body fluid, thereby improving patient outcomes.
Career Highlights
Carlos Mora is associated with Hemotune AG, a company dedicated to advancing medical technologies. His work at Hemotune AG has positioned him as a key player in the development of novel treatment methods for critical health issues. His patent reflects his commitment to improving patient care through innovative solutions.
Collaborations
Carlos has collaborated with notable colleagues, including Lukas Langenegger and Jean-Claude Metzger. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medical innovation.
Conclusion
Carlos Mora's contributions to the field of extracorporeal treatment highlight his dedication to advancing medical technology. His innovative patent demonstrates the potential for improved treatment methods for patients suffering from sepsis.